<DOC>
	<DOCNO>NCT02635854</DOCNO>
	<brief_summary>Some study show antiplatelets agent could reduce organ dysfunction septic shock mouse human model . Platelets actor immunity activation complicate tissue damage vascular occlusion lead organ dysfunction . Investigators hypothesize increase platelet activation leukocyte-platelet aggregate septic shock .</brief_summary>
	<brief_title>Study Platelet Activation Septic Shock Patients</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>EXPERIMENTAL GROUP Patient possibly give oral agreement inclusion may sign consent intensive care Patients hospitalize general intensive care Patient hospitalize less 72 hour Patient suffer severe sepsis , whatever origin , hypotension ( PAs &lt; 90mmHg ) despite adequate fluid resuscitation vasoactive require use amine , hypoperfusion / least one organ dysfunction ( septic shock ) Patient Sequential Organ Failure Assessment ( SOFA ) score &gt; 8 ( &gt; 2 organ ) first 24 hour Patient enjoy social security scheme equivalent CONTROL GROUP Signed inform consent Patient see anesthesia consultation orthopedic knee prosthesis lay hip negative balance infectious Patient enjoy social security scheme equivalent EXPERIMENTAL GROUP Patient safeguard justice , guardianship Patient suffer haematological malignancy ( leukemia , lymphoma ... ) Patient suffer thrombocytopenia constitutional thrombopathy Pregnant CONTROL GROUP Patient safeguard justice , guardianship Patient infectious positive balance ( dental , urinary tract ) prior surgery Patient suffer haematological malignancy ( leukemia , lymphoma ... ) Patient suffer thrombocytopenia constitutional thrombopathy Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>leukocyte platelet aggregate</keyword>
	<keyword>platelet activation</keyword>
</DOC>